CONMED CORPORATION Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Portion Attributable to Parent
CONMED CORPORATION (CNMD) reported Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Portion Attributable to Parent of $2.13 million for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-04-29.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent · last filed 2013-04-29
- CONMED CORPORATION other comprehensive income (loss), derivatives qualifying as hedges, net of tax, portion attributable to parent for the quarter ending 2013-03-31 was $2.13M.
- CONMED CORPORATION other comprehensive income (loss), derivatives qualifying as hedges, net of tax, portion attributable to parent for the quarter ending 2012-09-30 was -$1.61M, a 137.44% decline year-over-year.
- CONMED CORPORATION other comprehensive income (loss), derivatives qualifying as hedges, net of tax, portion attributable to parent for the quarter ending 2012-06-30 was $292.00K, a 7.75% increase year-over-year.
- CONMED CORPORATION other comprehensive income (loss), derivatives qualifying as hedges, net of tax, portion attributable to parent for the quarter ending 2012-03-31 was -$1.56M.
| Period end | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Portion Attributable to Parent 9 month |
|---|---|---|---|
| 2013-03-31 | $2.13M 10-Q · filed 2013-04-29 | ||
| 2012-09-30 | -$1.61M 10-Q · filed 2012-10-29 | -$1.31M derived: sum of 2 quarters · filed 2012-10-29 | -$2.88M 10-Q · filed 2012-10-29 |
| 2012-06-30 | $292.00K 10-Q · filed 2012-07-30 | -$1.27M 10-Q · filed 2012-07-30 | |
| 2012-03-31 | -$1.56M 10-Q · filed 2013-04-29 | ||
| 2011-09-30 | $4.29M 10-Q · filed 2012-10-29 | $4.56M derived: sum of 2 quarters · filed 2012-10-29 | $3.52M 10-Q · filed 2012-10-29 |
| 2011-06-30 | $271.00K 10-Q · filed 2012-07-30 | -$775.00K 10-Q · filed 2012-07-30 | |
| 2011-03-31 | -$1.05M 10-Q · filed 2012-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |